A Study to Evaluate the Safety of mRNA-0184 in Participants With Heart Failure
Clinical trial NCT05659264 · COMPLETED
Trial details
- NCT number
- NCT05659264
- Sponsor
- ModernaTX, Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-12-05
- Primary completion
- 2024-12-17
- Enrollment
- 48
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.